These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 33071772)

  • 1. From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein.
    Heras-Garvin A; Stefanova N
    Front Synaptic Neurosci; 2020; 12():584536. PubMed ID: 33071772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion-like behaviour of alpha-synuclein.
    Rey NL; George S; Brundin P
    Neuropathol Appl Neurobiol; 2016 Feb; 42(1):51-76. PubMed ID: 26666838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-synuclein in Parkinson's disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction.
    Calabresi P; Mechelli A; Natale G; Volpicelli-Daley L; Di Lazzaro G; Ghiglieri V
    Cell Death Dis; 2023 Mar; 14(3):176. PubMed ID: 36859484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates.
    Neupane S; De Cecco E; Aguzzi A
    J Mol Biol; 2023 Jun; 435(12):167930. PubMed ID: 36566800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods.
    Tarutani A; Arai T; Murayama S; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2018 Apr; 6(1):29. PubMed ID: 29669601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
    Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
    Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Living in Promiscuity: The Multiple Partners of Alpha-Synuclein at the Synapse in Physiology and Pathology.
    Longhena F; Faustini G; Spillantini MG; Bellucci A
    Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30609739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies.
    Nakagaki T; Nishida N; Satoh K
    Front Aging Neurosci; 2021; 13():703984. PubMed ID: 34650422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FKBP12-immunopositive inclusions in patients with α-synucleinopathies.
    Honjo Y; Ayaki T; Horibe T; Ito H; Takahashi R; Kawakami K
    Brain Res; 2018 Feb; 1680():39-45. PubMed ID: 29246765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein misfolding and aggregation: Implications in Parkinson's disease pathogenesis.
    Mehra S; Sahay S; Maji SK
    Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):890-908. PubMed ID: 30853581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal live imaging of retinal α-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.
    Price DL; Rockenstein E; Mante M; Adame A; Overk C; Spencer B; Duong-Polk KX; Bonhaus D; Lindsey J; Masliah E
    Sci Rep; 2016 Jul; 6():29523. PubMed ID: 27389831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission.
    Imamura Y; Okuzumi A; Yoshinaga S; Hiyama A; Furukawa Y; Miyasaka T; Hattori N; Nukina N
    Commun Biol; 2022 Jun; 5(1):636. PubMed ID: 35768587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiome-Modified Polyphenolic Compounds Inhibit α-Synuclein Seeding and Spreading in α-Synucleinopathies.
    Yamasaki TR; Ono K; Ho L; Pasinetti GM
    Front Neurosci; 2020; 14():398. PubMed ID: 32431588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.
    Jellinger KA
    J Neural Transm (Vienna); 2018 Apr; 125(4):615-650. PubMed ID: 29222591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo.
    Lopez A; Gorb A; Palha N; Fleming A; Rubinsztein DC
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein: A Promising Biomarker for Parkinson's Disease and Related Disorders.
    Hatano T; Okuzumi A; Matsumoto G; Tsunemi T; Hattori N
    J Mov Disord; 2024 Apr; 17(2):127-137. PubMed ID: 38589016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology of synuclein aggregates.
    Duda JE; Lee VM; Trojanowski JQ
    J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple, versatile and robust centrifugation-based filtration protocol for the isolation and quantification of α-synuclein monomers, oligomers and fibrils: Towards improving experimental reproducibility in α-synuclein research.
    Kumar ST; Donzelli S; Chiki A; Syed MMK; Lashuel HA
    J Neurochem; 2020 Apr; 153(1):103-119. PubMed ID: 31925956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of the prion hypothesis of human synucleinopathies.
    Tamgüney G; Korczyn AD
    Cell Tissue Res; 2018 Jul; 373(1):213-220. PubMed ID: 29116402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.